bpc 157 fda warning 2025 news letters target marketers of unapproved weight loss drugs Federal health advisers are meeting

Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY New FDA peptide advisers could benefit from their own rulings STAT In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for FDA to discuss easing restrictions on peptides despite safety concerns US healthcare The Guardian

SKU: 70646494661 · From webdevsolutions.tech